Cost-Effectiveness Analysis Of Triple Therapy With Peginterferon, Ribavirin, And Boceprevir For The Treatment Of Chronic Hepatitis C Virus Genotype 1 With Severe Fibrosis Under “Real-Life” Conditions
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.822
https://www.valueinhealthjournal.com/article/S1098-3015(14)02752-1/fulltext
Title :
Cost-Effectiveness Analysis Of Triple Therapy With Peginterferon, Ribavirin, And Boceprevir For The Treatment Of Chronic Hepatitis C Virus Genotype 1 With Severe Fibrosis Under “Real-Life” Conditions
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)02752-1&doi=10.1016/j.jval.2014.08.822
First page :
A367
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
245